Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 21, 2020 07:15 ET | Source: Zealand Pharma

Zealand Pharma increases its share capital as a consequence of exercise of employee warrants

Company announcement – No. 44 / 2020 Zealand Pharma increases its share capital as a consequence of exercise of employee warrants Copenhagen, August 21, 2020 – Zealand Pharma A/S (“Zealand”)...
August 13, 2020 09:00 ET | Source: Zealand Pharma

Zealand Pharma announces acceleration of U.S. commercial operations through the completion of the Valeritas acquisition; FDA acceptance of New Drug Application submission for the dasiglucagon HypoPal® rescue pen; pipeline progress including

Interim report for H1 2020 Zealand Pharma announces acceleration of U.S. commercial operations through the completion of the Valeritas acquisition; FDA acceptance of New Drug Application...
August 06, 2020 04:00 ET | Source: Zealand Pharma

Zealand Pharma hosts conference call on August 13 at 4 pm CET (10am ET) to present second quarter results for 2020

Press Release – No. 42 / 2020 Zealand Pharma hosts conference call on August 13 at 4 pm CET (10am ET) to present second quarter results for 2020 Copenhagen, DK August 6, 2020 – Zealand Pharma A/S...
August 03, 2020 04:00 ET | Source: Zealand Pharma

Zealand Pharma Continues to Build Investor Relations and Communications Function with the Appointment of Mads Kronborg

Company announcement – No. 41 / 2020 Zealand Pharma Continues to Build Investor Relations and Communications Function with the Appointment of Mads Kronborg Bringing more than a decade of...
July 06, 2020 07:00 ET | Source: Zealand Pharma

Zealand Pharma Expands U.S. Operations, Opens New Boston Office

Company announcement – No. 40 / 2020 Zealand Pharma Expands U.S. Operations, Opens New Boston Office ·Commercial operations will be headquartered in Boston, as company looks to commercialize...
June 30, 2020 12:00 ET | Source: Zealand Pharma

Total number of shares and voting rights in Zealand Pharma at June 30, 2020

Company announcement – No. 39 / 2020 Total number of shares and voting rights in Zealand Pharma at June 30, 2020 Copenhagen, June 30, 2020 – Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL) (CVR-no. 20...
June 24, 2020 02:55 ET | Source: Zealand Pharma

Zealand Pharma announces first patient dosed in Phase 2 trial with long-acting GLP-1/glucagon dual agonist in obesity/diabetes

Company announcement – No. 38 / 2020 Zealand Pharma announces first patient dosed in Phase 2 trial with long-acting GLP-1/glucagon dual agonist in obesity/diabetes The 410-patient...
June 23, 2020 05:15 ET | Source: Zealand Pharma

Zealand Pharma major shareholder announcement: Sunstone Life Science Ventures

Company announcement – No. 37 / 2020 Zealand Pharma major shareholder announcement: Sunstone Life Science Ventures Copenhagen, June 23, 2020 – Zealand Pharma A/S ("Zealand") (Nadaq: ZEAL),...
June 22, 2020 05:15 ET | Source: Zealand Pharma

Zealand Pharma completes registration of capital increase

Company announcement – No. 36 / 2020 Zealand Pharma completes registration of capital increase NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN OR INTO THE UNITED...
June 17, 2020 18:25 ET | Source: Zealand Pharma

Zealand Pharma announces completion of directed issue and private placement of 2,684,461 new ordinary shares

Company announcement – No. 35 / 2020 Zealand Pharma announces completion of directed issue and private placement of 2,684,461 new ordinary shares NOT FOR RELEASE, PUBLICATION OR...